19509382

Source:http://linkedlifedata.com/resource/pubmed/id/19509382

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0023467, umls-concept:C0023981, umls-concept:C0677874, umls-concept:C0920317, umls-concept:C1504389, umls-concept:C1515895, umls-concept:C1955832
pubmed:issue	22
pubmed:dateCreated	2009-6-10
pubmed:abstractText	The optimal treatment of acute myeloid leukemia (AML) in first complete remission (CR1) is uncertain. Current consensus, based on cytogenetic risk, recommends myeloablative allogeneic stem cell transplantation (SCT) for poor-risk but not for good-risk AML. Allogeneic SCT, autologous transplantation, and consolidation chemotherapy are considered of equivalent benefit for intermediate-risk AML.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/P01 CA018029-36
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-10493204, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-10502596, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-10584742, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-10789670, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-11110676, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-11986202, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-12649129, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-12714526, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-12886238, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-14709737, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-15120937, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-15339677, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-15606550, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-15742336, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-1578910, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-15994282, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-16186596, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-1627322, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-16840201, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-16981667, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-17126723, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-17213292, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-1727924, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-17873123, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-18215777, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-18410898, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-18450602, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-18450603, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-1855097, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-18591623, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-19843898, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-2070137, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-3802833, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-7723385, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-7786990, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-8030632, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-8113835, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-8648394, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-9376578, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-9753069, http://linkedlifedata.com/resource/pubmed/commentcorrection/19509382-9921604
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1538-3598
pubmed:author	pubmed-author:AntinJoseph HJH, pubmed-author:AppelbaumFrederick RFR, pubmed-author:CutlerCoreyC, pubmed-author:DöhnerHartmutH, pubmed-author:DeAngeloDaniel JDJ, pubmed-author:DjulbegovicBenjamin JBJ, pubmed-author:HondaSumihisaS, pubmed-author:KopeckyKenneth JKJ, pubmed-author:KorethJohnJ, pubmed-author:SakamakiHisashiH, pubmed-author:SchlenkRichardR, pubmed-author:SierraJorgeJ, pubmed-author:SoifferRobert JRJ, pubmed-author:StoneRichard MRM, pubmed-author:WadleighMarthaM
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	301
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2349-61
pubmed:dateRevised	2011-9-13
pubmed:meshHeading	pubmed-meshheading:19509382-Antineoplastic Agents, pubmed-meshheading:19509382-Clinical Trials as Topic, pubmed-meshheading:19509382-Humans, pubmed-meshheading:19509382-Leukemia, Myeloid, Acute, pubmed-meshheading:19509382-Remission Induction, pubmed-meshheading:19509382-Risk Assessment, pubmed-meshheading:19509382-Stem Cell Transplantation, pubmed-meshheading:19509382-Survival Analysis, pubmed-meshheading:19509382-Transplantation, Homologous
pubmed:year	2009
pubmed:articleTitle	Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
pubmed:affiliation	Division of Hematologic Malignancies, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA. john_koreth@dfci.harvard.edu
pubmed:publicationType	Journal Article, Review, Meta-Analysis